Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Validation of biologic markers for use in research on chronic fatigue syndrome.

Authors
Schulte-PA
Source
Rev Infect Dis 1991 Jan; 13(1):S87-S89
NIOSHTIC No.
00209444
Abstract
Methodological issues in the use of biologic markers in research on the chronic fatigue syndrome (CFS) were discussed. The need for control and limitation of measurement errors, and the need for reliability of tests were addressed. The validity of a marker was critical in that it clearly represented the phenomenon being measured. The use of biologic markers in research required their validation as dependent or independent variables. The no effect threshold and the positive predictive value (PPV) of a marker were discussed. In population studies of CFS in which prevalence was low, the specificity of a marker weighed heavily in determining the PPV. Confounding factors, legal and ethical implications, base levels, and background levels were important considerations before use of markers. A checklist was provided for evaluating a biologic marker which included the availability of evidence for the validity of the marker, conditions necessary, multiple markers, and impact on the subject. The author cautions that biologic markers should only be considered tools to be added to the battery of those already existing, and that they should not be thought of as conclusive by themselves.
Keywords
NIOSH-Author; Biochemical-tests; Biological-factors; Clinical-symptoms; Epidemiology; Physiological-fatigue; Clinical-diagnosis
CODEN
RINDDG
Publication Date
19910101
Document Type
Journal Article
Fiscal Year
1991
NTIS Accession No.
NTIS Price
Issue of Publication
1
ISSN
0162-0886
NIOSH Division
DSHEFS
Source Name
Reviews of Infectious Diseases
State
OH
TOP